{"news_desk": null, "print_page": null, "section_name": "false", "subsection_name": "false", "byline": {"original": "By AMIE TSANG", "person": [{"rank": 1, "role": "reported", "firstname": "Amie", "organization": "", "lastname": "TSANG"}]}, "abstract": "Fidelity Seen as Muscling In | Pearson Discusses Selling Economist Stake | Bitcoin is the New Ransom Currency | China Stock Sell-Off", "type_of_material": "Blog", "word_count": "1699", "lead_paragraph": null, "pub_date": "2015-07-27T07:08:49Z", "document_type": "blogpost", "slideshow_credits": null, "headline": {"main": "Morning Agenda: Teva to Buy Allergan Generic Drug Unit", "kicker": "News"}, "snippet": "Fidelity Seen as Muscling In | Pearson Discusses Selling Economist Stake | Bitcoin is the New Ransom Currency | China Stock Sell-Off", "multimedia": [], "web_url": "http://news.blogs.nytimes.com/2015/07/27/morning-agenda-teva-to-buy-allergan-generic-drug-unit/", "keywords": [{"rank": "1", "value": "Ackman, William A", "name": "persons"}, {"rank": "1", "value": "Actavis PLC", "name": "organizations"}, {"rank": "2", "value": "Allergan Inc", "name": "organizations"}, {"rank": "3", "value": "Deutsche Bank AG", "name": "organizations"}, {"rank": "4", "value": "Drugs (Pharmaceuticals)", "name": "organizations"}, {"rank": "5", "value": "Exor SpA", "name": "organizations"}, {"rank": "6", "value": "Fidelity Investments", "name": "organizations"}, {"rank": "7", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "8", "value": "UBS A.G.", "name": "organizations"}, {"rank": "9", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "1", "value": "Bitcoin (Currency)", "name": "subject"}, {"rank": "11", "value": "Private Equity", "name": "subject"}, {"rank": "12", "value": "Puerto Rico", "name": "subject"}, {"rank": "13", "value": "Stocks and Bonds", "name": "subject"}, {"rank": "14", "value": "Venture Capital", "name": "subject"}, {"rank": "2", "value": "Bloomberg LP", "name": "subject"}, {"rank": "3", "value": "Botox (Drug)", "name": "subject"}, {"rank": "4", "value": "Carlyle Group LP", "name": "subject"}, {"rank": "5", "value": "China", "name": "subject"}, {"rank": "6", "value": "Futures and Options Trading", "name": "subject"}, {"rank": "7", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "8", "value": "National Debt (US)", "name": "subject"}, {"rank": "9", "value": "News and News Media", "name": "subject"}, {"rank": "10", "value": "Pearson PLC", "name": "subject"}], "blog": [], "_id": "55b611cc38f0d8556445e8fe", "source": "The New York Times"}